When I co-founded Jazz Pharmaceuticals, our vision was to create a company with a constant focus on patients and a commitment to being a great place to work.”
20th Anniversary of Jazz Pharmaceuticals founding
Acquired pre-clinical Pan-RAF inhibitor program from Redx Pharma
Entered into strategic collaboration with Codiak BioSciences
Opened new manufacturing facility in Athlone, Ireland and received a Facility of the Year Award in 2017 from the International Society for Pharmaceutical Engineering (ISPE) for Best Project Execution
Acquired Orphan Medical and its product, Xyrem®
Management team assembled/capital raised
Jazz Pharmaceuticals founded
This page is intended for U.S. residents only. We are not accepting requests from individuals in states other than California, Washington and Nevada. If you are not a resident of any of these states, please do NOT continue.
Please select and enter the required fields on the form below. We need this information to process your request and to take necessary steps to verify your identity. We will contact you if we need any additional information.
Please note that your rights may vary under applicable state privacy laws and may be subject to limitations.